Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey W Lockman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|April 28, 2005
Recent developments in the identification of chemotherapeutics for Chagas diseaseJeffrey W Lockman, Andrew D Hamilton
Journal of Medicinal Chemistry|January 5, 2002
Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffoldJunko Ohkanda, Jeffrey W Lockman, Mohit A Kothare, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Oxindole derivatives as inhibitors of TAK1 kinaseJeffrey W Lockman, Matthew D Reeder, Rosann Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Inhibition of eEF2-K by thieno[2,3-b]pyridine analoguesJeffrey W Lockman, Matthew D Reeder, Kazuyuki Suzuki, et al.
Organic & Biomolecular Chemistry|February 1, 2006
Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferaseJunko Ohkanda, Corey L Strickland, Michelle A Blaskovich, et al.
Journal of Medicinal Chemistry|May 26, 2009
Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas diseasePraveen Kumar Suryadevara, Srinivas Olepu, Jeffrey W Lockman, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Journal of Medicinal Chemistry|November 18, 2010
Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)Jeffrey W Lockman, Brett R Murphy, Daniel F Zigar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|April 28, 2005
Recent developments in the identification of chemotherapeutics for Chagas diseaseJeffrey W Lockman, Andrew D Hamilton
Journal of Medicinal Chemistry|January 5, 2002
Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffoldJunko Ohkanda, Jeffrey W Lockman, Mohit A Kothare, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Oxindole derivatives as inhibitors of TAK1 kinaseJeffrey W Lockman, Matthew D Reeder, Rosann Robinson, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Inhibition of eEF2-K by thieno[2,3-b]pyridine analoguesJeffrey W Lockman, Matthew D Reeder, Kazuyuki Suzuki, et al.
Organic & Biomolecular Chemistry|February 1, 2006
Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferaseJunko Ohkanda, Corey L Strickland, Michelle A Blaskovich, et al.
Journal of Medicinal Chemistry|May 26, 2009
Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas diseasePraveen Kumar Suryadevara, Srinivas Olepu, Jeffrey W Lockman, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Journal of Medicinal Chemistry|November 18, 2010
Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt)Jeffrey W Lockman, Brett R Murphy, Daniel F Zigar, et al.
Pageof 1